Transdermal research and development company, 4P Therapeutics, opened its newly designed $250,000 headquarters facility in Peachtree Corners, Georgia
. Located at 680 Engineering Dr., Suite 150, the Gwinnett County facility encompasses 8,000 square feet, with the addition of another 5,000 square feet anticipated by the end of this year.
“Our new facility in Gwinnett will allow us to continue to enhance our research efforts, expand the company, and take advantage of the resources available to growing life sciences companies in Georgia,” stated Steven Damon, President & CEO of 4P Therapeutics. “With access to the region’s research support, top-rated universities, and biotechnology infrastructure, we are well positioned to expand our capabilities and products.”
Local economic development officials noted the company’s headquarters is located in the state’s Innovation Crescent, a corridor spanning from Atlanta to Athens-Clarke County, which attracts the resources of top research organizations in the Southeast contributing to life science exploration.
“4P Therapeutics is a fantastic addition to Gwinnett’s strong and growing bioscience industry,” said Gwinnett County Commission Chairman Charlotte Nash. “With direct access to the resources, opportunities, and support that help companies like 4P Therapeutics thrive, Gwinnett County is poised to remain a leader in life sciences.”
“4P Therapeutics joins a host of life science companies and further positions the community for sustained economic growth driven by research, development, and the commercialization of new products and technologies,” stated City of Peachtree Corners Mayor Mike Mason.
“4P Therapeutics is the type of thriving company we aim to attract, nurture, and retain in Georgia’s vibrant Innovation Crescent and I am excited to welcome them to the region,” said Nick Masino, Chairman of Georgia’s Innovation Crescent and Senior Vice President of Gwinnett Chamber Economic Development and Partnership Gwinnett. “We look forward to supporting 4P Therapeutics in Gwinnett, where we have proven that we have the talent and resources to help life science companies prosper.”